eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
1/2013
vol. 5
 
Share:
Send email
Share:
abstract:
Review paper

Prophylaxis and management of venous thromboembolism in patients with advanced cancer

Ewa Deskur-Śmielecka
,
Aleksandra Kotlińska-Lemieszek
,
Ewa Bączyk
,
Lidia Gorzelińska
,
Maciej Sopata

Medycyna Paliatywna 2013; 5(1): 8–13
Online publish date: 2013/04/16
View full text Get citation
 
Venous thromboembolism (VT) is a common problem in patients with advanced cancer, worsening the prognosis and quality of life. However, prophylaxis and treatment of VT in this population is controversial because of high risk of bleeding and shortage of evidence supporting such management. The decision to start anticoagulants must be taken individually, balancing risk of VT and bleeding, and burden of treatment. Patient’s preference should also be considered. In addition to the known contraindications, patients who are dying, or who are on end of life care pathway are not suitable for anticoagulation. There are some data to support thromboprophylaxis in hospitalized patients with acute medical conditions, subjects undergoing surgery lasting more than 30 minutes, and patients who have undergone hip replacement or hip fracture surgery. In contrast, there is no evidence of efficacy of prophylaxis in all inpatients with cancer. The treatment of choice is low molecular weight heparin.
keywords:

thromboembolism, advanced cancer, palliative care
FEATURED PRODUCTS
BOOKS
• Medycyna Paliatywna
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.